Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CANCER-THERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 920 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Leonard, KA; Deisseroth, AB; Austin, DJ
      Combinatorial chemistry in cancer drug development

      CANCER JOURNAL
    2. Rubinchik, S; Wang, D; Yu, H; Fan, F; Luo, M; Norris, JS; Dong, JY
      A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression

      MOLECULAR THERAPY
    3. Wu, XF; He, YK; Falo, LD; Hui, KM; Huang, L
      Regression of human mammary adenocarcinoma by systemic administration of arecombinant gene encoding the hFlex-TRAIL fusion protein

      MOLECULAR THERAPY
    4. Onda, M; Olafsen, T; Tsutsumi, Y; Bruland, OS; Pastan, I
      Cytotoxicity of antiosteosarcoma recombinant immunotoxins composed of TP-3Fv fragments and a truncated Pseudomonas exotoxin A

      JOURNAL OF IMMUNOTHERAPY
    5. Zogakis, TG; Libutti, SK
      General aspects of anti-angiogenesis and cancer therapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    6. Kriangkum, J; Xu, BW; Nagata, LP; Fulton, RE; Suresh, MR
      Bispecific and bifunctional single chain recombinant antibodies

      BIOMOLECULAR ENGINEERING
    7. Okamura, H; Morimoto, H; Haneji, T
      Peplomycin-induced apoptosis in oral squamous carcinoma cells depends on bleomycin sensitivity

      ORAL ONCOLOGY
    8. van Dijk, MA; van de Winkel, JGJ
      Human antibodies as next generation therapeutics

      CURRENT OPINION IN CHEMICAL BIOLOGY
    9. Nagane, M; Huang, HJS; Cavenee, WK
      The potential of TRAIL for cancer chemotherapy

      APOPTOSIS
    10. Henriksson, M; Selivanova, G; Lindstrom, M; Wiman, KG
      Inactivation of Myc-induced p53-dependent apoptosis in human tumors

      APOPTOSIS
    11. Barenholz, Y
      Liposome application: problems and prospects

      CURRENT OPINION IN COLLOID & INTERFACE SCIENCE
    12. Lao, YH
      Endogenous angiogenesis inhibitors and their therapeutic implications

      INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
    13. El-Deiry, WS
      Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling

      CELL DEATH AND DIFFERENTIATION
    14. Angelova, M; Dolashka-Angelova, P; Ivanova, E; Serkedjieva, J; Slokoska, L; Pashova, S; Toshkova, R; Vassilev, S; Simeonov, I; Hartmann, HJ; Stoeva, S; Weser, U; Voelter, W
      A novel glycosylated Cu/Zn-containing superoxide dismutase: production andpotential therapeutic effect

      MICROBIOLOGY-SGM
    15. Tognoni, A; Pensa, F; Vaira, F; Vigani, A; Bancalari, L; Fiasella, L; Maggiani, R; Canessa, P; Pronzato, P
      A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancer

      JOURNAL OF CHEMOTHERAPY
    16. Shopova, M; Peeva, M; Stoichkova, N; Jori, G; Wohrle, D; Petrov, G
      Light intensity effect on the mechanisms of tumor damage photosensitized by a substituted Zn(II)-naphthalocyanine

      JOURNAL OF PORPHYRINS AND PHTHALOCYANINES
    17. Wiehe, A; Simonenko, EJ; Senge, MO; Roder, B
      Hydrophilicity vs hydrophobicity-varying the amphiphilic structure of porphyrins related to the photosensitizer m-THPC

      JOURNAL OF PORPHYRINS AND PHTHALOCYANINES
    18. Ramachandra, M; Rahman, A; Zou, AH; Vaillancourt, M; Howe, JA; Antelman, D; Sugarman, B; Demers, GW; Engler, H; Johnson, D; Shabram, P
      Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy

      NATURE BIOTECHNOLOGY
    19. Buchsbaum, DJ; Curiel, DT
      Gene therapy for the treatment of cancer

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    20. Pollack, IF; Erff, M; Ashkenazi, A
      Direct stimulation of apoptotic signaling by soluble Apo2L/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells

      CLINICAL CANCER RESEARCH
    21. Sunwoo, JB; Chen, Z; Dong, G; Yeh, N; Bancroft, CG; Sausville, E; Adams, J; Elliott, P; Van Waes, C
      Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma

      CLINICAL CANCER RESEARCH
    22. Christ, O; Seiter, S; Matzku, S; Burger, C; Zoller, M
      Efficacy of local versus systemic application of antibody-cytokine fusion proteins in tumor therapy

      CLINICAL CANCER RESEARCH
    23. Teicher, BA; Menon, K; Alvarez, E; Galbreath, E; Shih, C; Faul, M
      Antiangiogenic and anitumor effects of a protein kinase C beta inhibitor in human T98G glioblastoma multiforme xenografts

      CLINICAL CANCER RESEARCH
    24. Tezuka, M; Watanabe, H; Nakamura, S; Yu, D; Aung, W; Sasaki, T; Shibuya, H; Miura, M
      Antiapoptotic activity is dispensable for insulin-like growth factor I receptor-mediated clonogenic radioresistance after gamma-irradiation

      CLINICAL CANCER RESEARCH
    25. Ding, HF; Fisher, DE
      P53, caspase 8, and regulation of apoptosis after ionizing radiation

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    26. Aksenova, AA; Sebyakin, YL; Mironov, AF
      Synthesis and properties of O- and S-glycosylated derivatives of pyropheophorbide alpha

      RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY
    27. Jung, M; Dritschilo, A
      NF-kappa B signaling pathway as a target for human tumor radiosensitization

      SEMINARS IN RADIATION ONCOLOGY
    28. Varghese, S; Newsome, JT; Rabkin, SD; McGeagh, K; Mahoney, D; Nielsen, P; Todo, T; Martuza, RL
      Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates

      HUMAN GENE THERAPY
    29. Reff, ME; Heard, C
      A review of modifications to recombinant antibodies: attempt to increase efficacy in oncology applications

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    30. Bodey, B; Bodey, B; Siegel, SE; Kaiser, HE
      Immunocytochemical detection of leukocyte-associated and apoptosis-relatedantigen expression in childhood brain tumors

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    31. Newton, DL; Hansen, HJ; Liu, HT; Ruby, D; Iordanov, MS; Magun, BE; Goldenberg, DM; Rybak, SM
      Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    32. Nash, KT; Thompson, JP; Debinski, W
      Molecular targeting of malignant gliomas with novel multiply-mutated interleukin 13-based cytotoxins

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    33. Galanis, E; Vile, R; Russell, SJ
      Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    34. Yang, XD; Jia, XC; Corvalan, JRF; Wang, P; Davis, CG
      Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    35. Duque, PM; Parada, C; Guinea, J; Sanchez-Prieto, R; Cajal, SRY
      Selective effects of E1B-defective adenoviruses and adenovirus E1A mutantsin deficient mouse primary embryonic fibroblasts

      INTERNATIONAL JOURNAL OF ONCOLOGY
    36. Baldus, SE; Goergen, D; Hanisch, FG; Dienes, HP
      Epitope-dependent differential immunoreactivities of anti-MUC1 monoclonal antibodies in human carcinomas

      INTERNATIONAL JOURNAL OF ONCOLOGY
    37. Martin, NMB
      DNA repair inhibition and cancer therapy

      JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
    38. Sun, X; Kanwar, JR; Leung, E; Lehnert, K; Wang, D; Krissansen, GW
      Gene transfer of antisense hypoxia inducible factor-1 alpha enhances the therapeutic efficacy of cancer immunotherapy

      GENE THERAPY
    39. Nuyts, S; Van Mellaert, L; Theys, J; Landuyt, W; Bosmans, E; Anne, J; Lambin, P
      Radio-responsive recA promoter significantly increases TNF alpha production in recombinant clostridia after 2 Gy irradiation

      GENE THERAPY
    40. Dupont, F; Karim, A; Dumon, JC; Mine, N; Avalosse, B
      A novel MVMp-based vector system specifically designed to reduce the risk of replication-competent virus generation by homologous recombination

      GENE THERAPY
    41. Lambright, ES; Amin, K; Wiewrodt, R; Force, SD; Lanuti, M; Propert, KJ; Litzky, L; Kaiser, LR; Albelda, SM
      Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy

      GENE THERAPY
    42. Gao, H; Hui, KM
      Synthesis of a novel series of cationic lipids that can act as efficient gene delivery vehicles through systematic heterocyclic substitution of cholesterol derivatives

      GENE THERAPY
    43. Kasai, S; Nagasawa, H; Yamashita, M; Masui, M; Kuwasaka, H; Oshodani, T; Uto, Y; Inomata, T; Oka, S; Inayama, S; Hori, H
      New antimetastatic hypoxic cell radiosensitizers: Design, synthesis, and biological activities of 2-nitroimidazole-acetamide, TX-1877, and its analogues

      BIOORGANIC & MEDICINAL CHEMISTRY
    44. Weissfloch, L; Wagner, M; Probst, T; Senekowitsch-Schmidtke, R; Tempel, K; Molls, M
      A new Class of Drugs for BNCT? Borylated derivatives of ferrocenium compounds in animal experiments

      BIOMETALS
    45. Zendman, AJW; de Wit, NJW; van Kraats, AA; Weidle, UH; Ruiter, DJ; van Muijen, GNP
      Expression profile of genes coding for melanoma differentiation antigens and cancer/testis antigens in metastatic lesions of human cutaneous melanoma

      MELANOMA RESEARCH
    46. Chatzistamou, I; Schally, AV; Varga, JL; Groot, K; Busto, R; Armatis, P; Halmos, G
      Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone

      ANTI-CANCER DRUGS
    47. Arencibia, JM; Schally, AV; Halmos, G; Nagy, A; Kiaris, H
      In vitro targeting of a cytotoxic analog of luteinizing hormone-releasing hormone AN-207 to ES-2 human ovarian cancer cells as demonstrated by microsatellite analyses

      ANTI-CANCER DRUGS
    48. Murata, R; Overgaard, J; Horsman, MR
      Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues

      INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    49. Um, JH; Kang, CD; Lee, BG; Kim, DW; Chung, BS; Kim, SH
      Increased and correlated nuclear factor-kappa B and Ku autoantigen activities are associated with development of multidrug resistance

      ONCOGENE
    50. Salih, HR; Nussler, V
      Commentary: Immune escape versus tumor tolerance: How do tumors evade immune surveillance?

      EUROPEAN JOURNAL OF MEDICAL RESEARCH
    51. Kuppen, PJK; van der Eb, MM; Jonges, LE; Hagenaars, M; Hokland, ME; Nannmlark, U; Goldfarb, RH; Basse, PH; Fleuren, GJ; Hoeben, RC; van de Velde, CJH
      Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer

      HISTOCHEMISTRY AND CELL BIOLOGY
    52. Bensel, N; Reymond, MT; Reymond, JL
      Pivalase catalytic antibodies: Towards abzymatic activation of prodrugs

      CHEMISTRY-A EUROPEAN JOURNAL
    53. Harvey, ML; Illidge, T; Johnson, P
      Antibodies in the treatment of lymphoma

      CLINICAL ONCOLOGY
    54. Lustig, B; Jeang, KT
      Biological applications of hammerhead ribozymes as anti-viral molecules

      CURRENT MEDICINAL CHEMISTRY
    55. Huang, ZQ; Waxman, DJ
      Modulation of cyclophosphamide-based cytochrome P450 gene therapy using liver P450 inhibitors

      CANCER GENE THERAPY
    56. Nakagawa, S; Massie, B; Hawley, RG
      Tetracycline-regulatable adenovirus vectors: pharmacologic properties and clinical potential

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    57. Nomura, M; Kaji, A; Ma, W; Miyamoto, K; Dong, Z
      Suppression of cell transformation and induction of apoptosis by caffeic acid phenethyl ester

      MOLECULAR CARCINOGENESIS
    58. Selenko, N; Majdic, O; Draxler, S; Berer, A; Jager, U; Knapp, W; Stockl, J
      CD20 antibody (C2B8)-induced apoptosis of lymphoma cells promotes phagocytosis by dendritic cells and cross-priming of CD8(+) cytotoxic T cells

      LEUKEMIA
    59. Zaffaroni, N; Fiorentini, G; De Giorgi, U
      Hyperthermia and hypoxia: new developments in anticancer chemotherapy

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    60. Prasad, KN; Cole, WC; Kumar, B; Prasad, KC
      Scientific rationale for using high-dose multiple micronutrients as an adjunct to standard and experimental cancer therapies

      JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
    61. Lee, BK; Yoo, YG; Lee, WY; Hong, CS; Park, JK; Ro, JY
      Ovalbumin fused with diphtheria toxin protects mice from ovalbumin inducedanaphylactic shock

      YONSEI MEDICAL JOURNAL
    62. Reichrath, J
      Will analogs of 1,25-dihydroxyvitamin D-3 (calcitriol) open a new era in cancer therapy?

      ONKOLOGIE
    63. Masunaga, S; Ono, K; Suzuki, M; Nishimura, Y; Kinashi, Y; Takagaki, M; Hori, H; Nagasawa, H; Uto, Y; Tsuchiya, I; Sadahiro, S; Murayama, C
      Radiosensitization effect by combination with paclitaxel in vivo, including the effect on intratumor quiescent cells

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    64. Sheridan, MT; West, CML
      Ability to undergo apoptosis does not correlate with the intrinsic radiosensitivity (SF2) of human cervix tumor cell lines

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    65. Russo, SM; Tepper, JE; Baldwin, AS; Liu, R; Adams, J; Elliott, P; Cusack, JC
      Enhancement of radiosensitivity by proteasome inhibition: Implications fora role of NF-kappa B

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    66. Xu, S; Zakian, K; Thaler, H; Matei, C; Alfleri, A; Chen, YC; Koutcher, JA
      Effects of motexafin gadolinium on tumor metabolism and radiation sensitivity

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    67. Ressel, A; Weiss, C; Feyerabend, T
      Tumor oxygenation after radiotherapy, chemotherapy, and/or hyperthermia predicts tumor free survival

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    68. Landuyt, W; Ahmed, B; Nuyts, S; Theys, J; de Beeck, MO; Rijnders, A; Anne, J; van Oosterom, A; Van den Bogaert, W; Lambin, P
      In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    69. Pruschy, M; Rocha, S; Zaugg, K; Tenzer, A; Hess, C; Fisher, DE; Glanzmann, C; Bodis, S
      Key targets for the execution of radiation-induced tumor cell apoptosis: The role of p53 and caspases

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    70. Bier, H; Hoffmann, T; Hauser, U; Wink, M; Ochler, M; Kovar, A; Muser, M; Knecht, R
      Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    71. Nakamura, K; Tanaka, Y; Shitara, K; Hanai, N
      Construction of humanized anti-ganglioside monoclonal antibodies with potent immune effector functions

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    72. Bok, BD
      Highlights of the European Association of Nuclear Medicine Congress, Paris2000

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    73. Kerbusch, T; de Kraker, J; Keizer, HJ; van Putten, JWG; Groen, HJM; Jansen, RLH; Schellens, JHM; Beijnen, JH
      Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites

      CLINICAL PHARMACOKINETICS
    74. Sprinzl, GM; Kacani, L; Schrott-Fischer, A; Romani, N; Thumfart, WF
      Dendritic cell vaccines for cancer therapy

      CANCER TREATMENT REVIEWS
    75. Liu, J; Flores, GA; Sheng, RS
      In-vitro investigation of blood embolization in cancer treatment using magnetorheological fluids

      JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
    76. Nakamura, Y; Shimizu, H; Nishijima, C; Ueno, M; Arakawa, Y
      Delayed functional recovery by vincristine after sciatic nerve crush injury: a mouse model of vincristine neurotoxicity

      NEUROSCIENCE LETTERS
    77. Chatzistamou, I; Schally, AV; Szepeshazi, K; Groot, K; Hebert, F; Arencibia, JM
      Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix

      CANCER LETTERS
    78. Munoz, R; Arias, Y; Ferreras, JM; Jimenez, P; Rojo, MA; Girbes, T
      Sensitivity of cancer cell lines to the novel non-toxic type 2 ribosome-inactivating protein nigrin b

      CANCER LETTERS
    79. Yoshimura, N; Sawada, T; Furusawa, M; Fuchinoue, S
      Expression of xenoantigen transformed human cancer cells to be susceptibleto antibody-mediated cell killing

      CANCER LETTERS
    80. Burkle, A
      Poly(APD-ribosyl)ation, a DNA damage-driven protein modification and regulator of genomic instability

      CANCER LETTERS
    81. Koelemij, R; Hagenaars, M; Ensink, NG; Eggermont, AMM; Van De Velde, CJH; Fleuren, GJ; Kuppen, PJK
      Administration of BiMAb-retargeted T cells in a rat hepatic metastases colon tumour model results in T-cell tumour infiltration independent of the route of administration

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    82. Siemens, DR; Ratliff, TL
      Vaccines in urologic malignancies

      UROLOGICAL RESEARCH
    83. Weinstein, JN
      Searching for pharmacogenomic markers: The synergy between omic and hypothesis-driven research

      DISEASE MARKERS
    84. Gerhardt, P
      Options for investigative postsurgical therapy for gastric cancer, and case report of using the option for combined immunotherapy and chemotherapy

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    85. Kaur, H; Richardson, E; Murty, L
      Preparation of monoclonal antibodies against human telomerase

      HYBRIDOMA
    86. Lopaczynski, W; Zeisel, SH
      Antioxidants, programmed cell death, and cancer

      NUTRITION RESEARCH
    87. Norton, EJ; Diekman, AB; Westbrook, VA; Flickinger, CJ; Herr, JC
      RASA, a recombinant single-chain variable fragment (scFv) antibody directed against the human sperm surface: implications for novel contraceptives

      HUMAN REPRODUCTION
    88. Murata, R; Overgaard, J; Horsman, MR
      Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid

      INTERNATIONAL JOURNAL OF HYPERTHERMIA
    89. Ohnishi, K; Ohnishi, T
      Heat-induced p53-dependent signal transduction and its role in hyperthermic cancer therapy

      INTERNATIONAL JOURNAL OF HYPERTHERMIA
    90. Wehner, H; von Ardenne, A; Kaltofen, S
      Whole-body hyperthermia with water-filtered infrared radiation: technical-physical aspects and clinical experiences

      INTERNATIONAL JOURNAL OF HYPERTHERMIA
    91. van den Elsen, JMH; Kuntz, DA; Rose, DR
      Structure of Golgi alpha-mannosidase II: a target for inhibition of growthand metastasis of cancer cells

      EMBO JOURNAL
    92. Liao, SX; Khare, PD; Arakawa, F; Kuroki, M; Hirose, Y; Fujimura, S; Tomita, Y; Kuroki, M
      Targeting of LAK activity to CEA-expressing tumor cells with an anti-CEA scFv/IL-2 fusion protein

      ANTICANCER RESEARCH
    93. Grunbaum, U; Meye, A; Bache, M; Bartel, F; Wurl, P; Schmidt, H; Dunst, J; Taubert, H
      Transfection with mdm2-antisense or wtp53 results in radio sensitization and an increased apoptosis of a soft tissue sarcoma cell line

      ANTICANCER RESEARCH
    94. Preston, TJ; Abadi, A; Wilson, L; Singh, C
      Mitochondrial contributions to cancer cell physiology: potential for drug development

      ADVANCED DRUG DELIVERY REVIEWS
    95. Reimoser, SA; Pavlovic, M
      Engineering design and study of the beam position accuracy in the "Riesenrad" ion gantry

      NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
    96. Mitra, S; Gaur, U; Ghosh, PC; Maitra, AN
      Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier

      JOURNAL OF CONTROLLED RELEASE
    97. Attawia, MA; Borden, MD; Herbert, KM; Katti, DS; Asrari, F; Uhrich, KE; Laurencin, CT
      Regional drug delivery with radiation for the treatment of Ewing's sarcoma- In vitro development of a taxol release system

      JOURNAL OF CONTROLLED RELEASE
    98. Hager, ED; Dziambor, H; Hohmann, D; Winkler, P; Strama, H
      Effects of lithium on thrombopoiesis in patients with low platelet cell counts following chemotherapy or radiotherapy

      BIOLOGICAL TRACE ELEMENT RESEARCH
    99. Wang, YY; Zhou, R; Liliemark, J; Gruber, A; Lindemalm, S; Albertioni, F; Liliemark, E
      In vitro topo II-DNA complex accumulation and cytotoxicity of etoposide inleukaemic cells from patients with acute myelogenous and chronic lymphocytic leukaemia

      LEUKEMIA RESEARCH
    100. Nuyts, S; Van Mellaert, L; Barbe, S; Lammertyn, E; Theys, J; Landuyt, W; Bosmans, E; Lambin, P; Anne, J
      Insertion or deletion of the Cheo box modifies radiation inducibility of Clostridium promoters

      APPLIED AND ENVIRONMENTAL MICROBIOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 18:38:05